- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2202
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Microglial Cx3cr1knockout reduces prion disease incubation time in mice ; volume:15 ; number:1 ; day:21 ; month:3 ; year:2014 ; pages:1-7 ; date:12.2014
BMC neuroscience ; 15, Heft 1 (21.3.2014), 1-7, 12.2014
- Creator
-
Grizenkova, Julia
- Contributor
-
Akhtar, Shaheen
Brandner, Sebastian
Collinge, John
Lloyd, Sarah E.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2202-15-44
- URN
-
urn:nbn:de:1111-2016032122102
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grizenkova, Julia
- Akhtar, Shaheen
- Brandner, Sebastian
- Collinge, John
- Lloyd, Sarah E.
- SpringerLink (Online service)
Other Objects (12)
α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
Effect of inoculation with prion dilutions within the dynamic range of ELISA absorbance on prion incubation period
Prions prions prions
The degree of astrocyte activation is predictive of the incubation time to prion disease
Electroacupuncture reduces cold stress-induced pain through microglial inactivation and transient receptor potential V1 in mice
The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation
Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation
The Absence of Prion-Like Infectivity in Mice expressing Prion Protein-Like Protein
OSGeo Incubation
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics
Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein
Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein
α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
Effect of inoculation with prion dilutions within the dynamic range of ELISA absorbance on prion incubation period
Prions prions prions
The degree of astrocyte activation is predictive of the incubation time to prion disease
Electroacupuncture reduces cold stress-induced pain through microglial inactivation and transient receptor potential V1 in mice
The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation
Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation
The Absence of Prion-Like Infectivity in Mice expressing Prion Protein-Like Protein
OSGeo Incubation
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics
Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein
Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein
α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
Effect of inoculation with prion dilutions within the dynamic range of ELISA absorbance on prion incubation period
Prions prions prions
The degree of astrocyte activation is predictive of the incubation time to prion disease
Electroacupuncture reduces cold stress-induced pain through microglial inactivation and transient receptor potential V1 in mice
The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation
Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation
The Absence of Prion-Like Infectivity in Mice expressing Prion Protein-Like Protein
OSGeo Incubation
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics
Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein